Abiopharma

News list

(80% Positive) NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) Provides Update on status for adults

Full text

News bot June 23, 2026, 9:02 p.m.
📋 NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) - Clinical Trial Update

Filing Date: 2026-06-23

Accepted: 2026-06-23 17:00:27

Event Type: Clinical Trial Update
Event Details:
NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) Announces Clinical Trial Update NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) provided an update on its clinical development programs. Clinical Development Highlights:
Drug Program: status, Approval
Diseases/Conditions: adults, non-invasive nose-to-brain delivery
Clinical Stage: Phase 1, Phase 2
Collaboration: Rare Pediatric Disease
💼 Business Developments:
- Partnership: Not available
- Acquisition: Not available
- Licensing: Not available
- Regulatory Approval
- Executive Changes: Not available
Structured Data:
- Company Name: NEONC TECHNOLOGIES HOLDINGS, INC.
- Ticker Symbol: NTHI